Nivata Wealth

ERIS · What Changed

What Changed at
Eris Lifesciences Limited?

See reported financial changes and material NSE disclosures for Eris Lifesciences Limited.

My CompaniesSaved on this device. No account needed.
Follow a company to build your personal change feed.

Latest company changes

Eris Lifesciences Limited

Start with what changed, then open the supporting financial and operating detail only when you need it.

ERIS · Consolidated

Eris Lifesciences Limited

Q1 FY27 Results

Q1 FY27

Latest reported changes

What Actually Changed

Worth reviewingNeutral / mixedNSE disclosure · 5 Oct 2026
Management

The company disclosed the resignation of Mr Krishnakumar vaidyanathan as Executive Director of the company w.e.f. close of September 30.
View NSE filing ↗
Financial snapshot

Latest Reported Financials

Available reported figures from the latest period.

Revenue from operations₹873.25 Cr
Q1 FY27
Total income₹875.64 Cr
Q1 FY27
Profit after tax₹143.32 Cr
Q1 FY27
EPS₹10.26
Q1 FY27
Profit before tax₹179.89 Cr
Q1 FY27
Supporting financial context

Margins and Supporting Figures

Only reported or directly calculated figures that are available for this company.

Supporting financial contextProfitability
PAT margin16.41%
Profit before tax₹179.89 Cr
Supporting financial contextSupporting reported figures
Finance cost₹46.65 Cr
Depreciation₹72.07 Cr
Tax₹36.17 Cr
Other income₹2.39 Cr
Today

Today on Nivata

Loading today’s changes…
— meaningful changes— companies

Checking the latest tracked company developments…